AspirinAnti-Inflammatory Agents, Non-SteroidalPlatelet Aggregation InhibitorsSalicylatesCyclooxygenase InhibitorsAnti-Inflammatory AgentsPlatelet AggregationThromboxane B2Prostanoic AcidsTiclopidineThromboxanesSodium SalicylateBlood PlateletsProstaglandin-Endoperoxide SynthasesIbuprofenAcetaminophenIndomethacinProstaglandinsPlatelet Function TestsDipyronePiroxicamFibrinolytic AgentsCyclooxygenase 1DiclofenacSalicylic AcidCyclooxygenase 2 InhibitorsDose-Response Relationship, DrugThromboxane A2Cyclooxygenase 2Gastrointestinal HemorrhageDinoprostoneAnticoagulantsInflammationDrug HypersensitivityDipyridamoleBleeding TimeProstaglandins EDouble-Blind MethodDrug InteractionsArachidonic Acid6-Ketoprostaglandin F1 alphaStomach UlcerDrug Therapy, CombinationPyrazolesTime FactorsEdemaThrombosisAnalgesicsAntipyreticsGentisatesGastric MucosaArachidonic AcidsEpoprostenolStomach DiseasesNaproxenGastrointestinal DiseasesSulfonamidesThromboembolismPhenacetinTreatment OutcomeWarfarinAnalgesics, Non-NarcoticCarrageenanRandom AllocationLipoxinsHemorrhagePlacebosCerebrovascular DisordersPlatelet AdhesivenessProspective StudiesPlatelet ActivationAcetic AcidPeptic UlcerCells, CulturedDisease Models, AnimalDrug ResistanceAdenosine DiphosphateIschemic Attack, TransientRisk FactorsTolmetinFlurbiprofenMyocardial InfarctionEtodolacCross-Over StudiesPainIsoenzymesTumor Necrosis Factor-alphaNanofibersRabbitsNitric OxideStrokeClinical Trials as TopicCardiovascular DiseasesCalotropisCytokinesIndicators and ReagentsAbsorbable ImplantsInflammation MediatorsMacrophagesPhenylbutazone